| PRIMERS |
SEQUENCES |
VENDORS |
| 3’ AD |
5’ (AGA TGG TGC ACG ATG CAC AG) 3’ |
BD Biosciences |
| 3 AOX1 |
5' (GCA AAT GGC ATT CTG ACA TCC) 3’ |
Invitrogen |
| 5’ AD |
5’ (TTC GAT GAT GAA GAT ACC CC) 3’ |
BD Biosciences |
| 5 AOX1 |
5' (GAC TGG TTC CAA TTG ACA AGC) 3’ |
Invitrogen |
| BGH Reverse |
5' (TAG AAG GCA CAG TCG AGG) 3' |
General |
| BK REVERSE |
5' (ACA GGA AAC AGC TAT GAC CTT G) 3' |
Stratagene |
| CAT-F |
5' (ATC CCA ATG GCA TCG TAA AG) 3' |
ACGT, Inc. |
| CAT-R |
5' (ACA GAC GGC ATG ATG AAC CT) 3' |
ACGT, Inc. |
| CMV Forward |
5' (CGC AAA TGG GCG GTA GGC GTG) 3’ |
Invitrogen |
| EF-1α Forward |
5' (TCA AGC CTC AGA CAG TGG TTC) 3’ |
Invitrogen |
| GEX 3‘ |
5’ (CCG GGA GCT GCA TGT GTC AGA GG) 3’ |
Amersham |
| GEX 3’B |
5’ (CAA GCT GTG ACC GTC TCC) 3’ |
Amersham |
| GEX 5‘ |
5’ (GGG CTG GCA AGC CAC GTT TGG TG) 3’ |
Amersham |
| GL Primer 1 |
5' (TGT ATC TTA TGG TAC TGT AAC TG) 3’ |
Promega |
| GL Primer 2 |
5' (CTT TAT GTT TTT GGC GTC TTC CA) 3' |
Promega |
| KS |
5’ (TCG AGG TCG ACG GTA TC) 3’ |
Stratagene |
| M13F (-20) |
5' (GTA AAA CGA CGG CCA GT) 3' |
General |
| M13F (-40) |
5' (GTT TTC CCA GTC ACG AC) 3' |
General |
| M13R |
5' (GGA AAC AGC TAT GAC CAT G) 3' |
General |
| myc-HIS Reverse |
5’ (ATG ACC GGT ATG CAT ATT CAG) 3’ |
Invitrogen |
| pBAD Forward |
5' (ATG CCA TAG CAT TTT TAT CC) 3’' |
Invitrogen |
| pBAD Reverse |
5' (GAT TTA ATC TGT ATC AGG) 3’ |
Invitrogen |
| pET Upstream Primer |
5' (ATG CGT CCG GCG TAG A) 3’ |
Novagen |
| pFastBacForward |
5' (GGA TTA TTC ATA CCG TCC CA) 3’ |
Life Technologies |
| pFastBac Reverse |
5' (CAA ATG TGG TAT GGC TGA TT) 3’ |
Life Technologies |
| pREP Forward |
5' (GCT CGA TAC AAT AAA CGC C) 3’ |
Invitrogen |
| pRSET Reverse |
5’ (TAG TTA TTG CTC AGC GGT GG) 3’ |
Invitrogen |
| pTrcHis Forward |
5' (GAG GTA TAT ATT AAT GTA TCG) 3’ |
Invitrogen |
| pTrcHis Reverse |
5' (GAT TTA ATC TGT ATC AGG) 3’ |
Invitrogen |
| pTRE 3’ |
5’ (CCA CAC CTC CCC CTG AAC) 3’ |
Clonetech |
| pTRE 5’ |
5' (CGC CTG GAG ACG CCA TCC) 3' |
Clonetech |
| QE Promoter |
5’ (CCG AAA AGT GCC ACC TG) 3’ |
Qiagen |
| QE Reverse |
5' (GTT CTG AGG TCA TTA CTG G) 3' |
Qiagen |
| RV Primer 3 |
5' (CTA GCA AAA TAG GCT GTC CC) 3' |
Promega |
| RV Primer 4 |
5' (GAC GAT AGT CAT GCC CCG CG) 3’ |
Promega |
| SK |
5’ (CTA GGT GAT CAA GAT CTC GC) 3’ |
Stratagene |
| SP6 |
5' (GAT TTA GGT GAC ACT ATA G) 3' |
General |
| SP6 Promoter |
5' (TAT TTA GGT GAC ACT ATA G) 3' |
Promega |
| T3 |
5' (AAT TAA CCC TCA CTA AAG GG) 3' |
General |
| T7 |
5' (TAA TAC GAC TCA CTA TAG GG) 3' |
General |
| T7 Reverse |
5' (TAG TTA TTG CTC AGC GGT GG) 3' |
General |
| T7 Term |
5' (GCT AGT TAT TGC TCA GCG G) 3' |
General |
| U19 |
5’ (GTT TTC CCA GTC ACG ACG T) 3’ |
Novagen |
| 21TA |
5' (TTT TTT TTT TTT TTT TTT TTT A) 3' |
ACGT, Inc. |
| 21TC |
5' (TTT TTT TTT TTT TTT TTT TTT C) 3' |
ACGT, Inc. |
| 21TG |
5' (TTT TTT TTT TTT TTT TTT TTT G) 3' |
ACGT, Inc. |
| 1012F |
5' (GCT GAC AGA CTA ACA GAC) 3' |
ACGT, Inc. |
| 1012R |
5' (GCA AAC AAC AGA TGG CTG GC) 3' |
ACGT, Inc. |
| XL39 |
5' (ATT AGG ACA AGG CTG GTG GG) 3' |
Origene |
| V1.5 |
5' (GGA CTT TCC AAA ATG TCG) 3' |
ACGT, Inc. |
| 3’ DNA-BD |
5' (TAA GAG TCA CTT TAA AAT TTG TAT) 3' |
Clonetech |
| pTRE2-3' |
5' (CAT TCT AAA CAA CAC CCT G ) 3' |
Clonetech |
| T7EEV |
5’ (AAG GCT AGA GTA CTT AAT ACG A) 3’ |
Promega |
| ACYCDuetUP1 |
5' (GGA TCT CGA CGC TCT CCC T) 3' |
Novagen |
| DuetDOWN1 |
5'(GAT TAT GCG GCC GTG TAC AA) 3' |
Novagen |
| DuetUP2 |
5' (TTG TAC ACG GCC GCA TAA TC) 3 |
Novagen |
Print this Page]
